Written answers
Wednesday, 17 January 2024
Department of Health
Medicinal Products
Denis Naughten (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source
1791. To ask the Minister for Health when adjuvant abemaciclib will be approved to reduce the risk of breast cancer for patients; and if he will make a statement on the matter. [1861/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments